Cover Image
Market Research Report
Product code 
1068739

Global Gene Therapy Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Gene Therapy Market 2022-2026
Published: March 31, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the gene therapy market and it is poised to grow by $ 4.02 bn during 2022-2026 progressing at a CAGR of 19.84% during the forecast period. Our report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in special drug designations, benefits associated with gene therapy, and the rising geriatric population.

The gene therapy market analysis includes therapy area segment and geographic landscape.

Technavio's gene therapy market is segmented as below:

By Therapy Area

  • Oncology
  • CNS
  • Opthalmology
  • Rare diseases
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing research in gene therapy for CVDs and orphan diseases as one of the prime reasons driving the gene therapy market growth during the next few years. Also, partnerships and collaborations are changing the market scenario, and rapid growth potential in developing economies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gene therapy market covers the following areas:

  • Gene therapy market sizing
  • Gene therapy market forecast
  • Gene therapy market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Applied Genetic Technologies Corp., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio, Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc, Sangamo Therapeutics Inc., Sibiono GeneTech Co. Ltd., uniQure NV, and Voyager Therapeutics Inc. Also, the gene therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73059

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Therapy Area

  • 5.1 Market segments
  • Exhibit 24: Chart on Therapy Area - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Therapy Area - Market share 2021-2026 (%)
  • 5.2 Comparison by Therapy Area
  • Exhibit 26: Chart on Comparison by Therapy Area
  • Exhibit 27: Data Table on Comparison by Therapy Area
  • 5.3 Oncology - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
  • 5.4 CNS - Market size and forecast 2021-2026
  • Exhibit 32: Chart on CNS - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on CNS - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on CNS - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on CNS - Year-over-year growth 2021-2026 (%)
  • 5.5 Opthalmology - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Opthalmology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Opthalmology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Opthalmology - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Opthalmology - Year-over-year growth 2021-2026 (%)
  • 5.6 Rare diseases - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Rare diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 41: Data Table on Rare diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 42: Chart on Rare diseases - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Rare diseases - Year-over-year growth 2021-2026 (%)
  • 5.7 Others - Market size and forecast 2021-2026
  • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.8 Market opportunity by Therapy Area
  • Exhibit 48: Market opportunity by Therapy Area ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 52: Chart on Geographic comparison
  • Exhibit 53: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 UK - Market size and forecast 2021-2026
  • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 Japan - Market size and forecast 2021-2026
  • Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 90: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 93: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 94: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 95: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 96: Matrix on vendor position and classification
  • 10.3 Abeona Therapeutics Inc.
  • Exhibit 97: Abeona Therapeutics Inc. - Overview
  • Exhibit 98: Abeona Therapeutics Inc. - Product / Service
  • Exhibit 99: Abeona Therapeutics Inc. - Key offerings
  • 10.4 Amgen Inc.
  • Exhibit 100: Amgen Inc. - Overview
  • Exhibit 101: Amgen Inc. - Product / Service
  • Exhibit 102: Amgen Inc. - Key offerings
  • 10.5 Biogen Inc.
  • Exhibit 103: Biogen Inc. - Overview
  • Exhibit 104: Biogen Inc. - Product / Service
  • Exhibit 105: Biogen Inc. - Key offerings
  • 10.6 bluebird bio Inc.
  • Exhibit 106: bluebird bio Inc. - Overview
  • Exhibit 107: bluebird bio Inc. - Product / Service
  • Exhibit 108: bluebird bio Inc. - Key offerings
  • 10.7 F. Hoffmann La Roche Ltd.
  • Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.8 Gilead Sciences Inc.
  • Exhibit 114: Gilead Sciences Inc. - Overview
  • Exhibit 115: Gilead Sciences Inc. - Product / Service
  • Exhibit 116: Gilead Sciences Inc. - Key news
  • Exhibit 117: Gilead Sciences Inc. - Key offerings
  • 10.9 Novartis AG
  • Exhibit 118: Novartis AG - Overview
  • Exhibit 119: Novartis AG - Business segments
  • Exhibit 120: Novartis AG - Key offerings
  • Exhibit 121: Novartis AG - Segment focus
  • 10.10 Orchard Therapeutics Plc
  • Exhibit 122: Orchard Therapeutics Plc - Overview
  • Exhibit 123: Orchard Therapeutics Plc - Product / Service
  • Exhibit 124: Orchard Therapeutics Plc - Key offerings
  • 10.11 Sibiono GeneTech Co. Ltd.
  • Exhibit 125: Sibiono GeneTech Co. Ltd. - Overview
  • Exhibit 126: Sibiono GeneTech Co. Ltd. - Product / Service
  • Exhibit 127: Sibiono GeneTech Co. Ltd. - Key offerings
  • 10.12 uniQure NV
  • Exhibit 128: uniQure NV - Overview
  • Exhibit 129: uniQure NV - Product / Service
  • Exhibit 130: uniQure NV - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 131: Inclusions checklist
  • Exhibit 132: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 133: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 134: Research methodology
  • Exhibit 135: Validation techniques employed for market sizing
  • Exhibit 136: Information sources
  • 11.5 List of abbreviations
  • Exhibit 137: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Therapy Area - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Therapy Area - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Therapy Area
  • Exhibits27: Data Table on Comparison by Therapy Area
  • Exhibits28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on CNS - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on CNS - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on CNS - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on CNS - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Opthalmology - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Opthalmology - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Opthalmology - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Opthalmology - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Rare diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibits41: Data Table on Rare diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibits42: Chart on Rare diseases - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Rare diseases - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits48: Market opportunity by Therapy Area ($ million)
  • Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits52: Chart on Geographic comparison
  • Exhibits53: Data Table on Geographic comparison
  • Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits88: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits90: Market opportunity By Geographical Landscape ($ million)
  • Exhibits91: Impact of drivers and challenges in 2021 and 2026
  • Exhibits92: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits93: Overview on factors of disruption
  • Exhibits94: Impact of key risks on business
  • Exhibits95: Vendors covered
  • Exhibits96: Matrix on vendor position and classification
  • Exhibits97: Abeona Therapeutics Inc. - Overview
  • Exhibits98: Abeona Therapeutics Inc. - Product / Service
  • Exhibits99: Abeona Therapeutics Inc. - Key offerings
  • Exhibits100: Amgen Inc. - Overview
  • Exhibits101: Amgen Inc. - Product / Service
  • Exhibits102: Amgen Inc. - Key offerings
  • Exhibits103: Biogen Inc. - Overview
  • Exhibits104: Biogen Inc. - Product / Service
  • Exhibits105: Biogen Inc. - Key offerings
  • Exhibits106: bluebird bio Inc. - Overview
  • Exhibits107: bluebird bio Inc. - Product / Service
  • Exhibits108: bluebird bio Inc. - Key offerings
  • Exhibits109: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits110: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits111: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits112: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits113: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits114: Gilead Sciences Inc. - Overview
  • Exhibits115: Gilead Sciences Inc. - Product / Service
  • Exhibits116: Gilead Sciences Inc. - Key news
  • Exhibits117: Gilead Sciences Inc. - Key offerings
  • Exhibits118: Novartis AG - Overview
  • Exhibits119: Novartis AG - Business segments
  • Exhibits120: Novartis AG - Key offerings
  • Exhibits121: Novartis AG - Segment focus
  • Exhibits122: Orchard Therapeutics Plc - Overview
  • Exhibits123: Orchard Therapeutics Plc - Product / Service
  • Exhibits124: Orchard Therapeutics Plc - Key offerings
  • Exhibits125: Sibiono GeneTech Co. Ltd. - Overview
  • Exhibits126: Sibiono GeneTech Co. Ltd. - Product / Service
  • Exhibits127: Sibiono GeneTech Co. Ltd. - Key offerings
  • Exhibits128: uniQure NV - Overview
  • Exhibits129: uniQure NV - Product / Service
  • Exhibits130: uniQure NV - Key offerings
  • Exhibits131: Inclusions checklist
  • Exhibits132: Exclusions checklist
  • Exhibits133: Currency conversion rates for US$
  • Exhibits134: Research methodology
  • Exhibits135: Validation techniques employed for market sizing
  • Exhibits136: Information sources
  • Exhibits137: List of abbreviations